Patent portfolio

Protecting the architecture of a new lymphatic health category.

The Lymphex portfolio is designed to protect device geometry, energy systems, analytics, and platform pathways that make lymphatic intervention measurable, scalable, and defensible.

Download full patent

Device geometry

Protected form factors and application surfaces.

Energy systems

Multi-modal stimulation protocols and sequencing.

Platform moat

Analytics, indication expansion, and cloud intelligence.

Patent overview

Lymphex Provisional Patent Portfolio

Filing status: Provisional Patent Application

A comprehensive multi-modal platform for assessment, stimulation, and monitoring of lymphatic system function. The platform integrates photographic assessment (LymphLens), consumer-grade mechanical stimulation (LymphRelief), clinical-grade therapeutic intervention (LymphRestore), and cloud-based data analytics to enable personalized lymphatic health management.

Multi-modal energy system architecture

Programmable stimulation protocols

AI-driven assessment and indication expansion

Cloud data platform and analytics

Core claims

The claims protect how the platform works, not just what it looks like.

Patent claim

Multi-faceted spherical applicator with programmable contact geometry for targeted lymphatic stimulation

Patent claim

Integrated RF, red light, NIR, mechanical vibration, and thermal modulation for synergistic lymphatic activation

Patent claim

Cloud-based AI platform for population-level lymphatic health analytics and indication expansion

Patent claim

Non-invasive assessment methodology for quantifying lymphatic drainage capacity and dysfunction

Patent claim

Programmable protocol sequencing for indication-specific therapeutic intervention

Extracted figures

Illustrations from the provisional filing.

Anatomy, mechanism, and device architecture

Fig. 1

Device Form Factor

Side elevation of the consumer handheld device showing dual-lobe design

Fig. 3

Faceted Spherical Applicator

Detail view of the multi-faceted applicator geometry for targeted contact

Fig. 5

Primary Lymphatic Drainage Pathways

Anatomical illustration of the lymphatic drainage system

Fig. 6

Glymphatic System Schematic

Schematic of the brain glymphatic system and its dependence on peripheral lymphatics

IP strategy

A layered moat around intervention, measurement, and data flywheel effects.

Comprehensive patent portfolio protecting device, methodology, and platform. The portfolio supports a differentiated market position by protecting not only a device, but the full pathway from assessment to protocol-driven therapy and data capture.

Innovation summary

Consumer data can inform clinical trial design and evidence generation.

Clinical results can expand indication strategy and reimbursement pathways.

Protected device architecture keeps the ecosystem coherent across tiers.